MEMasaki Endo

Masaki Endo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Masaki Endo has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Hisatomo Kondo

    Oral Implantology and Regenerative Dental Medicine, Tokyo Medical and Dental University, Tokyo, Japan

    1 shared publication
  • Keiichi Ohya

    Pharmacology, Department of Hard Tissue Engineering, Tokyo Medical and Dental University, Tokyo, Japan

    1 shared publication
  • Shinji Kuroda

    Oral Implantology and Regenerative Dental Medicine, Tokyo Medical and Dental University, Tokyo, Japan

    1 shared publication
  • Shohei Kasugai

    Oral Implantology and Regenerative Dental Medicine, Tokyo Medical and Dental University, Tokyo, Japan

    1 shared publication
  • Yutaka Maruoka

    Oral and Maxillofacial Surgery, Tokyo Medical and Dental University, Tokyo, Japan

    1 shared publication

Latest Publications

  • Bone Regeneration by Modified Gene-Activated Matrix: Effectiveness in Segmental Tibial Defects in Rats

    by Masaki Endo, Shinji Kuroda, Hisatomo Kondo, Yutaka Maruoka, Keiichi Ohya, Shohei Kasugai

    Gene-activated matrix (GAM) is a matrix, such as collagen-containing plasmid vector, that encodes a protein to stimulate tissue regeneration. In the original GAM system, gene transfer efficiency was extremely low. We have recently reported that modifying GAM with calcium-phosphate precipitates (CaP) enhances the efficiency of gene transfer. The purpose of this study was to evaluate the effects of our modified GAM on tissue regeneration. We prepared critical size segmental bone defects in rat tibiae and transplanted GAM consisting of bovine atelocollagen and expression plasmid vector (bmp2), which encodes human BMP2, with or without CaP. The tibiae were later examined radiographically, histologically, and mechanically. Implantation of bmp2-CaP-collagen at 12 microg bmp2 bridged the bone defect at 4 weeks, and the strength of the bone was comparable to that of an intact tibia at 6 weeks. Implantation of bmp2-collagen at the same dose of bmp2 bridged the defect to a smaller extent. Neither collagen alone nor vacant vector-CaP-collagen bridged the defect. These results indicate that our modified GAM with CaP has the potential to be effective in tissue regeneration at lower plasmid DNA doses than used in previous studies.